Mid-life antihypertensive initiation and incident dementia: a machine learning-weighted target trial emulation in the health and retirement study
{{output}}
Background: Mid-life hypertension is a treatable vascular risk for dementia, yet trial evidence on whether starting antihypertensives in middle age lowers late-life dementia remains mixed. This study aimed to emulate a randomized... ...
